Benjamin M. Kagina - Concepedia

Author

Benjamin M. Kagina

Also Known As

Alana Keyser, B Kagina, B M Kagina, B. Kagina, B. M. Kagina, Benjamin Kagina, Benjamin M Kagina, Benjamin M. Kagina, Benjamin M. N. Kagina, Benjamin M.N. Kagina

104

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Cape Town South African Tuberculosis Vaccine Initiative Stellenbosch University Aeras Statens Serum Institut

About

Benjamin M. Kagina is an author at University of Cape Town specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	600
2	Epidemiology	6	6	98
3	Public Health	4	4	63
4	Child Development	1	1	13
5	Global Health	1	1	13

Benjamin M. Kagina

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns Benjamin M. Kagina, Thomas J. Scriba, E. Jane Hughes, American Journal of Respiratory and Critical Care Medicine	2010	404
Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis Sara Suliman, Ethan Thompson, Jayne S. Sutherland, American Journal of Respiratory and Critical Care Medicine	2018	261
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults Angelique Kany Kany Luabeya, Benjamin M. Kagina, Michèle Tameris, Vaccine VaccinationPulmonary TuberculosisTuberculosis PreventionImmunologyMycobacterium Tuberculosis	2015	190
Metabolite changes in blood predict the onset of tuberculosis January Weiner, Jeroen Maertzdorf, Jayne S. Sutherland, Nature Communications	2018	153
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response Benjamin M. Kagina, Mark Bowmaker, Thomas J. Scriba, Vaccine VaccinationVaccinologyBcg VaccinationImmunologyTherapeutic Vaccine	2009	109
Improving vaccination uptake among adolescents Leila Abdullahi, Benjamin M. Kagina, Charles Shey Wiysonge, Cochrane Database of Systematic Reviews	2015	72
Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease Lerisa Govender, E. Jane Hughes, Thomas J. Scriba, Vaccine Pulmonary TuberculosisAdaptive Immune SystemTuberculosis DiseasePathogenesisImmunology	2010	66
Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry Benjamin M. Kagina, Nazma Mansoor, Eloi Kpamegan, Journal of Immunological Methods Flow CytometryAutoimmune DiseaseLaboratory ImmunologyAdaptive Immune SystemHematology	2014	61
Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial Klaus Reither, L. Katsoulis, Trevor Beattie, PLoS ONE	2014	58
The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses Benjamin M. Kagina, Michèle Tameris, Hennie Geldenhuys, Vaccine VaccinationVaccinologyPulmonary TuberculosisVaccine DevelopmentMedicine	2014	50

Page 1